描述

Safety data from the four-probiotic IBS trial reveal no serious adverse events in either group. Mild gastrointestinal symptoms reported during treatment are transient and self-limiting.

Figure 12

Chart

Source Paper

Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.

Probiotics and antimicrobial proteins (2019)

PMID: 29508268

DOI: 10.1007/s12602-018-9401-3

Cite This Figure

![Figure 12: Safety data from the four-probiotic IBS trial reveal no serious adverse events in either group. Mild gastrointestinal symptoms reported during treatment are transient and self-limiting.]()

> Source: Konstantinos Leventogiannis et al. "Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritabl." *Probiotics and antimicrobial proteins*, 2019. PMID: [29508268](https://pubmed.ncbi.nlm.nih.gov/29508268/)

<figure>
  <img src="" alt="Safety data from the four-probiotic IBS trial reveal no serious adverse events in either group. Mild gastrointestinal symptoms reported during treatment are transient and self-limiting." />
  <figcaption>Figure 12. Safety data from the four-probiotic IBS trial reveal no serious adverse events in either group. Mild gastrointestinal symptoms reported during treatment are transient and self-limiting.<br>  Source: Konstantinos Leventogiannis et al. "Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritabl." <em>Probiotics and antimicrobial proteins</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29508268/">29508268</a></figcaption>
</figure>

描述

Figure 12

Source Paper

Cite This Figure

相关证据